Pindolol (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Pindolol drug offered from Cadila Healthcare Limited. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | Pindolol |
SUBSTANCE NAME: | PINDOLOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-11-07 |
END MARKETING DATE: | 0000-00-00 |
Pindolol HUMAN PRESCRIPTION DRUG Details:
Item Description | Pindolol from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2017-11-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70771-1134_d4078b63-30ad-435b-a081-4d90562962b5 |
PRODUCT NDC: | 70771-1134 |
APPLICATION NUMBER: | ANDA209866 |
Other PINDOLOL Pharmaceutical Manufacturers / Labelers: